Skip to main content
. 2018 Jan 9;14:95–104. doi: 10.2147/TCRM.S149325

Figure 4.

Figure 4

Linear dose–response relationship between circulating 25[OH]D concentration and prostate cancer.

Note: Weights are from random effects analysis.

Abbreviations: 25[OH]D, 25-hydroxyvitamin D; CI, confidence interval; RR, relative risk.